Cleared Traditional

K162531 - STERISPINE CC

K162531 is the FDA 510(k) clearance for STERISPINE CC by Safe Orthopaedics. It is a Class 2 Orthopedic device (product code OVE) cleared through the Traditional 510(k) pathway after a 111-day FDA review.

K162531 · Safe Orthopaedics · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2016
Decision
111d
Days
Class 2
Risk

K162531 is an FDA 510(k) clearance for the STERISPINE CC. Classified as Intervertebral Fusion Device With Integrated Fixation, Cervical (product code OVE), Class II - Special Controls.

Submitted by Safe Orthopaedics (Eragny Sur Oise, FR). The FDA issued a Cleared decision on December 29, 2016 after a review of 111 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Safe Orthopaedics devices

Submission Details

510(k) Number K162531 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 09, 2016
Decision Date December 29, 2016
Days to Decision 111 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
11d faster than avg
Panel avg: 122d · This submission: 111d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OVE Intervertebral Fusion Device With Integrated Fixation, Cervical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft With Or Without Supplemental Fixation.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - OVE Intervertebral Fusion Device With Integrated Fixation, Cervical

All 111
Devices cleared under the same product code (OVE) and FDA review panel - the closest regulatory comparables to K162531.
SeaSpine Shoreline ACS - Anterior Cervical Standalone System
K170569 · SeaSpine Orthopedics Corporation · Jun 2017
NuVasive CoRoent Small Interlock II System
K170961 · Nu Vasive, Incorporated · Jun 2017
Spine Wave Anterior Cervical Spine System
K162760 · Spine Wave, Inc. · Feb 2017
NuVasive® CoRoent® Small Interlock™ System
K161442 · Nu Vasive, Incorporated · Sep 2016
SeaSpine Shoreline ACS - Anterior Cervical Standalone System
K161081 · SeaSpine Orthopedics Corporation · Sep 2016
Pro-Link® Stand-Alone Cervical Spacer System
K160066 · Life Spine, Inc. · Sep 2016